TP53 and lung adenocarcinoma: In another study, NSCLC organoids were derived from lung adenocarcinoma using a TP53 activator (nutlin) to eliminate normal lung stem cells and organoids were used as a potential drug screening model from which findings could be correlated to molecular markers.